Viewing Study NCT05241392


Ignite Creation Date: 2025-12-24 @ 3:40 PM
Ignite Modification Date: 2026-02-20 @ 6:46 AM
Study NCT ID: NCT05241392
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-02-11
First Post: 2022-01-13
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Efficacy Study of Anti-B7-H3 CAR-T Cell Therapy for Recurrent Glioblastoma
Sponsor: Beijing Tiantan Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module